Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J ends Given Imaging distribution

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson's Ethicon Endo-Surgery/InScope unit terminates a May 2004 pact with Given Imaging under which InScope marketed Given's PillCam ESO capsule endoscopy system in the United States for visualizing the esophagus. Given, which previously indicated that the relationship was not meeting its expectations, notes that J&J cited a "shift in its strategic priorities within gastroenterology and other areas as the reason for ending the relationship." InScope will pay Given $7.6 million in termination fees. As a result of the agreement, Given will record income of $13.5 million in the fourth quarter of 2007 and $12.5 million in the first half of 2008. InScope will continue to support reimbursement and marketing related activities for up to six months, and continue to pay for ongoing clinical trials associated with esophageal diseases, Given says. Given will continue to market the device on its own (1"The Gray Sheet" May 17, 2004, p. 22)
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT025476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel